Use of montelukast to reduce infusion reactions in an early access treatment protocol of daratumumab in united states patients with relapsed or refractory multiple myeloma

Category Primary study
JournalBlood
Year 2016
This article has no abstract
Epistemonikos ID: 37fd467e625649e137025f9b8f324d8f683f75bf
First added on: Feb 08, 2025